US Stock MarketDetailed Quotes

ARPO Aerpio Pharmaceuticals

Watchlist
  • 0.000
  • 0.0000.00%
Close Nov 22 09:30 ET
0Market Cap0.00P/E (TTM)

About Aerpio Pharmaceuticals Company

Aerpio Pharmaceuticals Inc is a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases. The company's product razuprotafib is a small molecule Tie2 activator being developed for the topical ocular treatment of primary open-angle glaucoma. Other products under the pipeline are ARP-1536 and AKB-4924.

Company Profile

SymbolARPO
Company NameAerpio Pharmaceuticals
CEODr. Joseph Gardner, PhD
MarketNASDAQ
Employees12
Fiscal Year Ends12-31

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Joseph Gardner, PhD
  • Director, President and Principal Executive Officer
  • --
  • Regina Marek
  • Vice President of Finance, Principal Financial and Accounting Officer
  • --
  • Steven Prelack
  • Chairman of the Board
  • --
  • Dr. Caley Castelein, M.D.
  • Independent Director
  • --
  • Cheryl L. Cohen
  • Independent Director
  • --
  • Pravin Dugel
  • Independent Director
  • --
  • Anupam Dalal
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data